0
0
Read Time:12 Second
Biocon shares ended more than 6% lower on Wednesday in the wake of U.S. Food and Drug Administration (U.S. FDA) classifying the insulin manufacturing facility of the drugmaker’s stepdown Malaysian subsidiary as Official Action Indicated (OAI). Biocon…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %